Physician profile

Justin E Trivax

Cardiovascular Disease · Bingham Farms, MI

NPI 1174566095

$119,346.12

in general payments reported to CMS, 2019-2025

52 companies · $1,702 in 2025

The $1,702 reported for 2025 was more than what 81% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

See the full distribution for Cardiovascular Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$19,397.00
Food and Beverage$5,933.64
Consulting Fee$31.20

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Janssen Pharmaceuticals, INC $94,986.53 2019-2024 Xarelto
Novartis Pharmaceuticals Corporation $9,627.00 2019-2025
Medtronic, INC. $2,709.76 2021-2025 Symplicity G3, Corevalve Evolut R, Onyx Frontier
Boston Scientific Corporation $2,408.15 2019-2025 Avvigo Guidance System, Cds - Mct/Cem Monitoring, Synergy
Medtronic Vascular, INC. $1,506.11 2019-2020
Amgen INC. $1,163.79 2019-2025 Repatha, Repatha
Merck Sharp & Dohme LLC $772.70 2021-2025 Verquvo, Capvaxive
E.R. Squibb & Sons, L.L.C. $588.63 2019-2025 Camzyos, Eliquis
Astrazeneca Pharmaceuticals LP $509.63 2019-2025 Wainua, Farxiga
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $420.63 2019-2025 Lifevest
Alnylam Pharmaceuticals INC. $419.80 2020-2025 Onpattro, Amvuttra
Pfizer INC. $410.63 2019-2024
Lilly USA, LLC $379.02 2023-2025 Mounjaro, Zepbound
Esperion Therapeutics, INC. $375.66 2020-2025 Nexletol
Boehringer Ingelheim Pharmaceuticals, INC. $311.69 2019-2025 Jardiance
Show all 52 companies
CompanyGeneral paymentsYearsTop products
Imperative Care, INC $212.12 2023-2024 Symphony Catheter, Prodigy Catheter
Amarin Pharma, INC. $211.04 2019-2021
Novo Nordisk INC $198.30 2021-2025 Wegovy, Ozempic, Rybelsus
Abbott Laboratories $162.07 2021-2025 Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, Amplatzer Amulet
Penumbra, INC. $150.35 2020-2021
Lexicon Pharmaceuticals, INC. $148.50 2023-2024 Inpefa
Chiesi USA, INC. $135.46 2020-2023 Kengreal
Actelion Pharmaceuticals US, INC. $132.43 2019-2025 Opsumit, Uptravi
Kowa Pharmaceuticals America, INC. $125.70 2019-2021
Regeneron Healthcare Solutions, INC. $119.21 2019-2022
Kiniksa Pharmaceuticals, LTD. $105.76 2022-2023 Arcalyst
Edwards Lifesciences Corporation $88.64 2019-2024 Edwards Sapien 3 Ultra Transcatheter Heart Valve
Kiniksa Pharmaceuticals International, Plc $87.31 2024 Arcalyst
Bardy Diagnostics, INC. $86.40 2020-2022
Scpharmaceuticals INC. $75.29 2024-2025
Sanofi-Aventis U.S. LLC $53.65 2019-2023
Tactile Systems Technology INC $53.53 2021-2022
Heartflow, INC. $52.13 2019-2023 Ffrct
Lundbeck LLC $50.55 2019-2020
Abiomed $49.15 2023-2025 Impella
Baxter Healthcare $46.80 2023 Hillrom - Carnation Ambulatory Monitor
United Therapeutics Corporation $46.23 2023-2024 Tyvaso
Daiichi Sankyo INC. $43.09 2023 Injectafer
Vital Connect, INC $38.11 2024 Vitalpatch Rtm
Recor Medical INC $37.32 2024-2025 Paradise Ultrasound Renal Denervation System, Paradise Renal Denervation System
Cardiovascular Systems INC. $32.38 2021-2023 Diamondback Peripheral
Medicomp INC $32.10 2019-2022
Kestra Medical Technology Services, INC. $29.73 2025 Assure Wcd
Astellas Pharma US INC $23.38 2019
Teleflex LLC $19.64 2023 Guideliner
Angiodynamics, INC. $19.02 2021
Arbor Pharmaceuticals, INC. $18.47 2020
Vivaquant INC, Dba Rhythm Express $16.00 2025 Rhythm Express
Irhythm Technologies, INC. $15.79 2019
Bridgebio Pharma, INC. $15.08 2025 Attruby
Philips North America LLC $13.91 2019
Ge Healthcare $11.75 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Justin E Trivax

$119,346.12

in general payments reported 2019-2025

Years
2019-2025
Top company
Janssen Pharmaceuticals, INC
Context
The $1,702 reported for 2025 was more than what 81% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/189747/justin-e-trivax

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.